| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT05627362 A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… |
Primary endpoint(s) modified |
| 2026-06-09 | NCT05627362 A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… |
Trial arms changed: 4 -> 5 |
| 2026-06-09 | NCT05627362 A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… |
date change Primary completion pushed: 2026-08-28 -> 2031-09-23 |
| 2026-06-09 | NCT05627362 A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… |
date change Completion pushed: 2026-08-28 -> 2031-09-23 |
| 2026-06-02 | NCT06016842 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis |
Trial sites expanded: 180 -> 183 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07387549 | A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With… | Primary Sclerosing Cholangitis | Recruiting |
| NCT06016842 | A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis | Primary Biliary Cholangitis (PBC) | Recruiting |
| NCT06383403 | A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response… | Primary Biliary Cholangitis | Active, Not Recruiting |
| NCT06730061 | A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis… | Primary Biliary Cholangitis | Active, Not Recruiting |
| NCT04526665 | Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) | Primary Biliary Cirrhosis | Active, Not Recruiting |
| Phase 2 | |||
| NCT05627362 | A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… | Primary Sclerosing Cholangitis | Active, Not Recruiting |